We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




First POC Genetic Test Diagnoses Lactose Intolerance Near Patient in Less Than 90 Minutes

By LabMedica International staff writers
Posted on 05 Sep 2023

Lactose intolerance is a medical condition marked by difficulty in digesting lactose due to reduced activity or synthesis of the enzyme lactase, which breaks down lactose into its basic sugars. A specific genetic variant called the −13910 C/T single nucleotide polymorphism within the MCM6 gene is linked to lactase persistence or non-persistence traits in the Caucasian population. Diagnosing lactose intolerance is crucial for implementing dietary adjustments or appropriate treatments. Now, a new point-of-care isothermal lab-on-phone lactose intolerance assay rapidly diagnoses primary lactose intolerance using direct buccal swabs or capillary blood samples with high accuracy and at low cost.

STAB VIDA (Caparica, Portugal) has developed an isothermal lab-on-phone lactose intolerance CE-IVD (In Vitro Diagnostic) marked point-of-care diagnostic assay called STAB VIDA Lda which is based on the loop-mediated isothermal amplification (LAMP) methodology followed by mutation probe-based melting curve analysis. The assay is automatically processed in real time using the Doctor Vida system, an inexpensive and portable device controlled through a user-friendly mobile app. This CE-IVD portable, handheld device facilitates isothermal nucleic acid amplification for a wide range of genetic biomarkers. Combining efficiency, accuracy, and affordability, this compact lab-on-phone lactose intolerance detection assay can prove highly valuable in managing symptoms for individuals with lactose intolerance. Moreover, it differentiates between primary and secondary forms of hypolactasia, with the former arising from genetic mutations in the enhancer region and the latter resulting from small intestine damage.

In a study, researchers evaluated the POC isothermal lab-on-phone lactose intolerance assay using buccal swabs and capillary blood samples, comparing its performance with the Sanger sequencing assay that examined the -13,910 C/T SNP in blood samples. The assay's detection limit was also determined across different sample concentrations. The findings showed that the STAB VIDA Lda isothermal lactose intolerance assay effectively identified the -13910 C/T SNP with a limit of detection of five cells per assay, achieving 98.41% accuracy for buccal swabs and 100% accuracy for capillary blood samples. The entire process, from sample collection to result retrieval, was completed in just 90 minutes, with merely two minutes of hands-on time. The detection limit achieved by the STAB VIDA Lda assay was comparable to established gold-standard methods like Sanger sequencing and PCR-based assays.

Related Links:
STAB VIDA 

New
Platinum Member
Flu SARS-CoV-2 Combo Test
OSOM® Flu SARS-CoV-2 Combo Test
Magnetic Bead Separation Modules
MAG and HEATMAG
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
Gold Member
TORCH Panel Rapid Test
Rapid TORCH Panel Test
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get complete access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: The new ADLM guidance will help healthcare professionals navigate respiratory virus testing in a post-COVID world (Photo courtesy of 123RF)

New ADLM Guidance Provides Expert Recommendations on Clinical Testing For Respiratory Viral Infections

Respiratory tract infections, predominantly caused by viral pathogens, are a common reason for healthcare visits. Accurate and swift diagnosis of these infections is essential for optimal patient management.... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Microbiology

view channel
Image: The POC PCR test shortens time for STI test results (Photo courtesy of Visby Medical)

POC STI Test Shortens Time from ED Arrival to Test Results

In a 2024 sexually transmitted infections (STIs) surveillance report by the World Health Organization (WHO), over 2.5 million cases were recorded, alongside a rise in the inappropriate use of antibiotics... Read more

Industry

view channel
Image: For 46 years, Roche and Hitachi have collaborated to deliver innovative diagnostic solutions (Photo courtesy of Roche)

Roche and Hitachi High-Tech Extend 46-Year Partnership for Breakthroughs in Diagnostic Testing

Roche (Basel, Switzerland) and Hitachi High-Tech (Tokyo, Japan) have renewed their collaboration agreement, committing to a further 10 years of partnership. This extension brings together their long-standing... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.